These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35154107)

  • 1. CD36 is Associated With the Development of Coronary Artery Lesions in Patients With Kawasaki Disease.
    Guo MM; Huang YH; Wang FS; Chang LS; Chen KD; Kuo HC
    Front Immunol; 2022; 13():790095. PubMed ID: 35154107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
    Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease.
    Huang YH; Chen KD; Lo MH; Cai XY; Chang LS; Kuo YH; Huang WD; Kuo HC
    Int J Med Sci; 2019; 16(4):576-582. PubMed ID: 31171909
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N; Gao Y; Wang Y; Dai Y; Tang Y; Huang J; Sun L; Qian G; Ma J; Li X; Liu Y; Yang D; Huang X; Wang W; Li W; Zhuo W; Lv H; Liu Z
    Int Immunopharmacol; 2024 Sep; 139():112698. PubMed ID: 39029232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
    Zhang J; Gui YH; Yang Y
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
    Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
    J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
    Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
    Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease.
    Terai M; Yasukawa K; Honda T; Jibiki T; Hirano K; Sato J; Ishiwada N; Seguchi M; Ueda S; Kohno Y
    Pediatr Infect Dis J; 2002 Aug; 21(8):777-81. PubMed ID: 12192168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease.
    Ohashi R; Fukazawa R; Shimizu A; Ogawa S; Ochi M; Nitta T; Itoh Y
    Vasc Med; 2019 Dec; 24(6):484-492. PubMed ID: 31621532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease.
    Yamamura K; Ihara K; Ikeda K; Nagata H; Mizuno Y; Hara T
    Int J Immunogenet; 2012 Apr; 39(2):119-25. PubMed ID: 22117627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
    Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
    Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
    Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
    J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
    Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
    Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.